{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T19:04:15Z","timestamp":1767035055733},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-024-09833-9","type":"journal-article","created":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:07:22Z","timestamp":1726664842000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Safety of remdesivir in the treatment of acute SARS-CoV-2 infection in pediatric patients"],"prefix":"10.1186","volume":"24","author":[{"given":"Brittany","family":"Player","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna R.","family":"Huppler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy Y.","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melodee","family":"Liegl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter L.","family":"Havens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Graff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"key":"9833_CR1","unstructured":"AAP. Children and COVID-19. State-level data report: American Academy of Pediatrics; \u00a0[updated March 2, 2023]. Available from: https:\/\/www.aap.org\/en\/pages\/2019-novel-coronavirus-covid-19-infections\/children-and-covid-19-state-level-data-report\/."},{"key":"9833_CR2","doi-asserted-by":"publisher","unstructured":"Woodruff RC, Campbell AP, Taylor CA, Chai SJ, Kawasaki B, Meek J, et al. Risk factors for severe COVID-19 in children. Pediatrics. 2022;149(1). Epub 2021\/12\/23. https:\/\/doi.org\/10.1542\/peds.2021-053418. PubMed PMID: 34935038; PubMed Central PMCID: PMC9213563.","DOI":"10.1542\/peds.2021-053418"},{"key":"9833_CR3","doi-asserted-by":"publisher","unstructured":"Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J. 2021;40(4):e137\u2013e45. Epub 2021\/02\/05. https:\/\/doi.org\/10.1097\/INF.0000000000003043. PubMed PMID: 33538539.","DOI":"10.1097\/INF.0000000000003043"},{"issue":"19","key":"9833_CR4","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","volume":"383","author":"JH Beigel","year":"2020","unstructured":"Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the treatment of Covid-19 - final report. N Engl J Med. 2020;383(19):1813\u201326. https:\/\/doi.org\/10.1056\/NEJMoa2007764. Epub 2020\/05\/24.","journal-title":"N Engl J Med"},{"issue":"4","key":"9833_CR5","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1056\/NEJMoa2116846","volume":"386","author":"RL Gottlieb","year":"2022","unstructured":"Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, et al. Early Remdesivir to prevent progression to severe Covid-19 in outpatients. N Engl J Med. 2022;386(4):305\u201315. https:\/\/doi.org\/10.1056\/NEJMoa2116846. Epub 2021\/12\/23.","journal-title":"N Engl J Med"},{"key":"9833_CR6","unstructured":"FDA. Remdesivir (Veklury) [package insert]. 2022."},{"issue":"19","key":"9833_CR7","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1056\/NEJMoa2015301","volume":"383","author":"JD Goldman","year":"2020","unstructured":"Goldman JD, Lye DCB, Hui DS, Marks KM, Bruno R, Montejano R, et al. Remdesivir for 5 or 10 days in patients with severe Covid-19. N Engl J Med. 2020;383(19):1827\u201337. https:\/\/doi.org\/10.1056\/NEJMoa2015301. Epub 2020\/05\/28.","journal-title":"N Engl J Med"},{"key":"9833_CR8","doi-asserted-by":"publisher","unstructured":"Goldman DL, Aldrich ML, Hagmann SHF, Bamford A, Camacho-Gonzalez A, Lapadula G, et al. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5). https:\/\/doi.org\/10.1542\/peds.2020-047803. Epub 2021\/04\/23.","DOI":"10.1542\/peds.2020-047803"},{"issue":"4","key":"9833_CR9","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/INF.0000000000003814","volume":"42","author":"AM Samuel","year":"2023","unstructured":"Samuel AM, Hacker LL, Zebracki J, Bogenschutz MC, Schulz L, Strayer J, et al. Remdesivir Use in Pediatric patients for SARS-CoV-2 treatment: single academic Center Study. Pediatr Infect Dis J. 2023;42(4):310\u20134. 0000000000003814. PubMed PMID: 36728726; PubMed Central PMCID: PMC9990481.","journal-title":"Pediatr Infect Dis J"},{"key":"9833_CR10","unstructured":"Gilead. Study of Remdesivir in Participants 18 Year Old and Younger With COVID-19 (CARAVAN) 2020, May -. https:\/\/ClinicalTrials.gov\/show\/NCT04431453. Identifier NCT04431453."},{"key":"9833_CR11","unstructured":"Ahmed ARP, Agwu A, Kimberlin D, Deville J, Mendez-Echevarria A, Sue P, Galli L, Shang Z, Juneja K, Hulter H, Hedskog C, Kersey K, Muller W, Munoz F. Remdesivir Treatment for COVID-19 in Hospitalized Children. CARAVAN Interim Results; 2022."},{"issue":"5","key":"9833_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1093\/jpids\/piab123","volume":"11","author":"JE Schuster","year":"2022","unstructured":"Schuster JE, Halasa NB, Nakamura M, Levy ER, Fitzgerald JC, Young CC, et al. A description of COVID-19-Directed Therapy in Children admitted to US Intensive Care Units 2020. J Pediatr Infect Dis Soc. 2022;11(5):191\u20138. https:\/\/doi.org\/10.1093\/jpids\/piab123. Epub 2022\/01\/14.","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"2","key":"9833_CR13","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. PubMed PMID: 18929686; PubMed Central PMCID: PMC2700030.","journal-title":"J Biomed Inf"},{"key":"9833_CR14","unstructured":"Health NIo. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Accessed 2022."},{"key":"9833_CR15","unstructured":"Centers for Disease C. Underlying Medical Conditions Associated with Higher Risk for Severe COVID-19: Information for Healthcare Professionals. 2023."},{"key":"9833_CR16","unstructured":"US Department of Health and Human Services N, NIAID. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events. 2017."},{"issue":"1","key":"9833_CR17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/biomet\/80.1.27","volume":"80","author":"D Firth","year":"1993","unstructured":"Firth D. Bias reduction of Maximum Likelihood estimates. Biometrika. 1993;80(1):27\u201338.","journal-title":"Biometrika"},{"issue":"9","key":"9833_CR18","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1111\/liv.14887","volume":"41","author":"A Perez","year":"2021","unstructured":"Perez A, Cantor A, Rudolph B, Miller J, Kogan-Liberman D, Gao Q, et al. Liver involvement in children with SARS-COV-2 infection: two distinct clinical phenotypes caused by the same virus. Liver Int. 2021;41(9):2068\u201375. https:\/\/doi.org\/10.1111\/liv.14887. Epub 20210422.","journal-title":"Liver Int"},{"key":"9833_CR19","doi-asserted-by":"publisher","first-page":"110588","DOI":"10.1016\/j.clinbiochem.2023.110588","volume":"118","author":"MW Sumner","year":"2023","unstructured":"Sumner MW, Florin TA, Kuppermann N, Xie J, Tancredi DJ, Freedman SB, of the Pediatric Emergency Research Network Pern PERCPC-ST. Liver transaminase concentrations in children with acute SARS-CoV-2 infection. Clin Biochem. 2023;118:110588. https:\/\/doi.org\/10.1016\/j.clinbiochem.2023.110588. Epub 20230530.","journal-title":"Clin Biochem"},{"issue":"12","key":"9833_CR20","doi-asserted-by":"publisher","first-page":"e12723","DOI":"10.1111\/ijpo.12723","volume":"15","author":"YH Zhou","year":"2020","unstructured":"Zhou YH, Zheng KI, Targher G, Byrne CD, Zheng MH. Abnormal liver enzymes in children and infants with COVID-19: a narrative review of case-series studies. Pediatr Obes. 2020;15(12):e12723. https:\/\/doi.org\/10.1111\/ijpo.12723. Epub 20200901.","journal-title":"Pediatr Obes"},{"issue":"2","key":"9833_CR21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1056\/NEJMc2007617","volume":"383","author":"N Parri","year":"2020","unstructured":"Parri N, Lenge M, Buonsenso D. Coronavirus Infection in Pediatric Emergency Departments Research G. Children with Covid-19 in Pediatric Emergency Departments in Italy. N Engl J Med. 2020;383(2):187\u201390. Epub 20200501. doi: 10.1056\/NEJMc2007617. PubMed PMID: 32356945; PubMed Central PMCID: PMC7206930.","journal-title":"N Engl J Med"},{"issue":"17","key":"9833_CR22","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMc2005073","volume":"382","author":"X Lu","year":"2020","unstructured":"Lu X, Zhang L, Du H, Zhang J, Li YY, Qu J, et al. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663\u20135. Epub 20200318. doi: 10.1056\/NEJMc2005073. PubMed PMID: 32187458; PubMed Central PMCID: PMC7121177.","journal-title":"N Engl J Med"},{"issue":"3","key":"9833_CR23","doi-asserted-by":"publisher","first-page":"57","DOI":"10.5409\/wjcp.v12.i3.57","volume":"12","author":"R Bitar","year":"2023","unstructured":"Bitar R, Elghoudi AA, Rawat D, Azaz A, Miqdady M, Narchi H. COVID-19-induced liver injury in infants, children, and adolescents. World J Clin Pediatr. 2023;12(3):57\u201367. https:\/\/doi.org\/10.5409\/wjcp.v12.i3.57. Epub 20230609.","journal-title":"World J Clin Pediatr"},{"issue":"8","key":"9833_CR24","doi-asserted-by":"publisher","first-page":"e28","DOI":"10.1016\/S2352-4642(20)30178-4","volume":"4","author":"DJ Stewart","year":"2020","unstructured":"Stewart DJ, Hartley JC, Johnson M, Marks SD, du Pre P, Stojanovic J. Renal dysfunction in hospitalised children with COVID-19. Lancet Child Adolesc Health. 2020;4(8):e28\u20139. https:\/\/doi.org\/10.1016\/S2352-4642(20)30178-4. Epub 20200615.","journal-title":"Lancet Child Adolesc Health"},{"issue":"2","key":"9833_CR25","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1473-3099(21)00485-0","volume":"22","author":"F Ader","year":"2022","unstructured":"Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, et al. Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial. Lancet Infect Dis. 2022;22(2):209\u201321. https:\/\/doi.org\/10.1016\/S1473-3099(21)00485-0. Epub 2021\/09\/18.","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"9833_CR26","doi-asserted-by":"publisher","first-page":"e137","DOI":"10.1097\/INF.0000000000003043","volume":"40","author":"K Graff","year":"2021","unstructured":"Graff K, Smith C, Silveira L, Jung S, Curran-Hays S, Jarjour J, et al. Risk factors for severe COVID-19 in children. Pediatr Infect Dis J. 2021;40(4):e137\u201345. https:\/\/doi.org\/10.1097\/INF.0000000000003043. Epub 2021\/02\/05.","journal-title":"Pediatr Infect Dis J"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-024-09833-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-024-09833-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,18]],"date-time":"2024-09-18T13:09:26Z","timestamp":1726664966000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-024-09833-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["9833"],"URL":"https:\/\/doi.org\/10.1186\/s12879-024-09833-9","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,17]]},"assertion":[{"value":"15 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The need for informed consent was waived by the Children\u2019s Wisconsin Human Research Protection Program Institutional Review Board because of the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"KG receives research funding and is a consultant for BioFire Diagnostics, LLC and BioMerieux, Inc. The funder did not participate in the work.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Financial Disclosure Statement"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"987"}}